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The mergence of chloroquine resistance in Plasmodium falCciparum has necessitated the development of alternate strategies for chemotherapy and chemoprophylaxis. One approach has been the identification of drugs that do not possess any intrinsic antimalarial activity when used alone but that potentiate the effect of currently available antimalarial drugs, such as chloroquine.
We identified fluoxetine hydrochloride (Prozac), a commonly prescribed antidepressant, as another resistance modulator for drug-resistant P. falciparum.
Studies with chloroquine-resistant clones and isolates from-various geographical locations confirmed our initial observations with a chloroquine-resistant P. falciparum clone, W2.
Fluoxetine concentrations of 500 nM were found to effectively modulate chloroquine resistance by 66% in clone W2. In comparison, verapamil at similar concentrations was observed to modulate chloroquine resistance in clone W2 by 61%.
Neither fluoxetine nor verapamil was observed to possess any innate antimalarial activity. These data augment the current description of the chloroquine resistance phenotype and may provide additional insights into lead-directed synthesis of new antimalarial drugs.
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Fluoxetine hydrochloride; chloroquine resistance; The emergence of chloroquine resistance in Plasmodium falciparum has necessitated the development of S_ M alternate strategies for chemotherapy and chemoprophylaxis. One approach has been the identification of M drugs that do not possess any intrinsic antimalarial activity when used alone but that potentiate the effect of currently available antimalarial drugs, such as chloroquine. We identified fluoxetine hydrochloride (Prozac), a commonly prescribed antidepressant, as another resistance modulator for drug-resistant P. falciparum. Studies with chloroquine-resistant clones and isolates from various geographical locations confirmed our initial observations with a chioroquine-resistant P. fakiparum clone, W2. Fluoxetine concentrations of 500 nM were found to effectively modulate chloroquine resistance by 66% in clone W2. In comparison, verapamil at similar concentrations was observed to modulate chloroquine resistance in clone W2 by 61%. Neither fluoxetine nor verapamil was observed to possess any innate antimalarial activity. These data augment the current description of the chloroquine resistance phenotype and may provide additional insights into lead-directed synthesis of new antimalarial drugs.
Malaria is a significant source of morbidity in the world, ity, desipramine (3) and chlorpromazine (12), are effective with an estimated annual prevalence of 270 million infections modulators of chloroquine resistance; in contrast, penfluri-(19). It is a serious impediment to economic and agricultural dol (13, 17) has been found to potentiate mefloquine, halogrowth and development, particularly in less developed fantrine, and artemisinin. In addition, fluoxetine met certain countries. At present, the quinoline ring-containing drugs structural criteria previously established for resistance modremain the most efficacious drugs for chemoprophylaxis and ulators. Lipid solubility, two planar aromatic rings, a catichemotherapy of Plasmodium falciparum malaria. Chloroonic charge, and a tertiary nitrogen were found to be quine, a 4-aminoquinoline, has been the drug of choice for important characteristics for reversal modulators (2, 22) . several decades. However, the increasing prevalence and Whereas fluoxetine fulfilled these criteria, it is worth noting the degree of chioroquine resistance in regions endemic for that the structure is unlike those of other reported modula-P. falcparum malaria have substantially compromised its tors of chloroquine resistance, the tricyclic antidepressants clinical utility. Although more than 350,000 compounds have (desipramine), the phenathiazines (chlorpromazine), or the been evaluated for their antimalarial activities at the Walter calcium channel antagonists (verapamil) (Fig. 1 ). We present Reed Army Institute of Research, few new leads for drug in vitro data that identify fluoxetine as a reversal modulator development have been identified. Despite the development for chloroquine-resistant P. falciparum malaria. of mefloquine, halofantrine, and artemisinin as new blood schizonticides, few effective drugs with enhanced antimalarial activity, reduced cost, and low toxicity exist. In order to MATERIALS AND METHODS preserve the efficacies of current and future chemotherapeuParasite clones and isolates. Several well-characterized tic agents, alternative drug strategies must continually be clones and isolates of P. falciparum with different susceptideveloped, evaluated, and implemented. One approach that bility profiles were used for the drug assays described here. merits further investigation and possible implementation has
The clones W2 (15) and D6 (15) are reference clones from been the identification of drugs that, at subinhibitory conIndochina III and Sierra Leone isolates, respectively. The centrations, modulate chloroquine resistance. Such drugs threshold values for chloroquine susceptibility and resisinclude verapamil (14), desipramine (3), chlorpromazine tance were determined by using the reference chloroquine- !s3 ng/ml). IC 50 s greater than 4 ng of chloroquine per ml
Our rationale for screening fluoxetine hydrochloride were considered resistant. Clone GA3 is a clone of the GH2
(Prozac) as a potential modulator was based on our previous isolate obtained from Thailand. Clone 306 is a clone of the observations that various compounds with neuroleptic activ-IEC 51/84 isolate from Brazil. Nigeria 60 is a patient isolate recently collected from Africa. Clones GA3, 306, and W2
• Corresponding author, and isolate Nigeria 60 are chloroquine resistant. assays were performed in 96-well microtiter plates with 1% evaluate fluoxetine's modulation of chloroquine resistance, erythrocyte suspensions at 0.2 to 0.5% parasitemia in RPMI simultaneous studies were performed with verapamil, a drug 1640 supplemented with 25 mM HEPES (N-2-hydroxyethwhose reversal activity in P. falciparum has been well ylpiperazine-N'-2-ethanesulfonic acid), 32 nM NaHCO 3 , and documented (14). The IC 5 1s of each drug alone and of 10% human plasma. Microtiter plates were prepared with various drug combinations were determined. serial dilutions of drug to determine IC 5 os. Each plate Modulation of the susceptibility of the parasite to chlorocontaining parasites and drug was incubated at 37*C in an quine singularly and in the presence of the resistance modairtight Plexiglas box in the presence of 5% oxygen-5% ulator at predetermined concentrations was expressed as the carbon dioxide-90% nitrogen. After 24 h of incubation, response modification index (RMI) (12). RMIs were calcucultures were labeled with (Tables 1 and 2 ). isolates of P. falciparum to chloroquine alone and in combination with resistance modulators are presented in Tables  1 and 2 . The response of the chloroquine-susceptible para-DISCUSSION site clone D6 to the fluoxetine and chloroquine combination Preservation of the clinical utility of chloroquine reprewas found to be similar to that of the clone to verapamil and sents a significant concern and challenge for public health chloroquine (Tables 1 and 2 , respectively). For either comofficials and clinicians. The rapid spread of drug resistance bination of drug and resistance modulator, there was no has resulted in a concerted effort to disseminate new drugs potentiation of chloroquine in the susceptible parasite. Insuch as mefloquine, artemisinin, and halofantrine as alternadeed, the RMIs suggested that the effects of these modulatives for chemoprophylaxis and chemotherapy of P. falcitors were additive for chloroquine (Tables 1 and 2 ). Nor did parum malaria. However, with the notable exception of the reversal modulators used singly possess any significant mefloquine, these drugs have not been licensed in all counantimalarial activity. These data for fluoxetine and verapamil tries. Chloroquine remains the most attractive drug because are consistent with similar observations for other chloroof its availability and low cost. Therefore, we have been quine reversal agents (3, 12-14). interested in identifying and developing drug and antimalarIn contrast, the data obtained for clone W2, the chloroial drug combinations that may act to restore chloroquine quine-resistant parasite, suggested that fluoxetine is as effecactivity in chloroquine-resistant parasites. tive as verapamil at reversing chloroquine resistance (Table  The mechanism of action of fluoxetine is not well charac-2). At concentrations from 62.5 to 1,000 nM, the RMIs for terized; however, it is presumed to be a serotonin uptake fluoxetine and verapamil in combination with chloroquine inhibitor (10). It is this aspect of the drug's proposed action were not found to be different (1.06 to 0.18 and 0.95 to 0.21 that may have relevance to its effect on reversing chloroat 1,000 nM, respectively) (Tables 1 and 2) . quine resistance. It has been demonstrated that in drugTo confirm these observations, similar studies were perresistant human cell lines the extrusion of cytotoxic comformed with more recent clones and isolates from different pounds is mediated by an energy-dependent transport geographical locations. It has been reported that responses mechanism involving the P-170 glycoprotein encoded by to various reversal modulators are contingent upon the mdrl (9). The P. falciparum equivalent of the human mdrl gene, the pfmdr] gene, has been identified (8, 18) and identify potent resistance modulators without significant localized to the parasitic digestive vacuole (6). However, no neuroleptic effects. differences in the quantitation of the p-glycoprotein in chlo-
The continued identification of additional resistance modroquine-susceptible and -resistant clones were observed. It ulators such as fluoxetine will assist in the efforts to exquishas been reported that the accumulation of chloroquine is itely define the structure-activity relationships of these drugs less in resistant parasites than it is in susceptible parasites and the drug resistance phenotype and may provide evibecause of an active efflux mechanism (11).
dence for identifying the gene(s) and mechanisms involved in The proposed mechanism of reversal of resistance for the resistance phenotype. The selection criteria for modufluoxetine and other modulators of P. falciparum drug resislating antimalarial resistance may further be delineated on tance is unknown. Hypothetically, resistance modulators the basis of the general reversal activity of the drug, the inhibit the extrusion of these cytotoxic compounds from the geographical origin of the resistant parasite, and the specific parasite by competition for a binding site on the P-170 resistance phenotype addressed. glycoprotein. Presumably, this has been proposed as the mechanism of reversal in the human equivalent P-170 glyco-ACKNOWLEDGMENTS protein (4, 5). It is also possible that fluoxetine and other
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